Ofatumumab
id:
ofatumumab-168-7708064
title:
Ofatumumab
text:
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the European Union and other regions. Under the brand name Arzerra, it is approved for the treatment of certain types of chronic lymphocytic leukemia (CLL) in the United States. It is sold by Novartis under license from Genmab. The most common side effects for ofatumumab (
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Ofatumumab
date created:
2007-02-25T00:18:36Z
date modified:
2024-08-31T01:03:10Z
main entity:
{"identifier":"Q410656","url":"https://www.wikidata.org/entity/Q410656"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0e/Ofatumumab_3GIZ.png","width":2048,"height":2048}
fields total:
13
integrity:
16